A structural explanation of the effects of dissociated glucocorticoids on glucocorticoid receptor transactivation

Molecular Pharmacology

Volumn 85, Issue 2, 2014, Pages 226-236

  Dezitter, Xavier ^a,c   Fagart, Jérome ^b   Taront, Solenne ^a   Fay, Michel ^b   Masselot, Bernadette ^a   Hétuin, Dominique ^a   Formstecher, Pierre ^a   Rafestin Oblin, Marie Edith ^b   Idziorek, Thierry ^a  

^a Inst Natl de la Sante et de la R   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c Faculté des Sciences Pharmaceutiques et Biologiques Université de Lille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIFEPRISTONE; RU 782; RU 858; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONFOCAL MICROSCOPY; CRYSTAL STRUCTURE; DRUG RECEPTOR BINDING; FEMALE; HELA CELL; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HYDROGEN BOND; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION;

EID: 84891869160     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.085860     Document Type: Article

References (42)

1. Beato M, Chávez S, and Truss M (1996) Transcriptional regulation by steroid hormones. Steroids 61:240-251
2. Belvisi MG, Brown TJ, Wicks S, and Foster ML (2001a) New Glucocorticosteroids with an improved therapeutic ratio? Pulm Pharmacol Ther 14:221-227
3. Belvisi MG, Wicks SL, Battram CH, Bottoms SE, Redford JE, Woodman P, Brown TJ, Webber SE, and Foster ML (2001b) Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity. J Immunol 166:1975-1982
4. BenkoussaM, Brand C, DelmotteMH, Formstecher P, and Lefebvre P (2002) Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol 22:4522-4534
5. Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, and Willson TM et al. (2002) Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110:93-105
6. Buttgereit F and Scheffold A (2002) Rapid glucocorticoid effects on immune cells. Steroids 67:529-534
7. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, and Van der Saag PT (1995) Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9:401-412
8. Carpentier R, Sacchetti P, Ségard P, Staels B, and Lefebvre P (2008) The glucocorticoid receptor is a co-regulator of the orphan nuclear receptor Nurr1 J Neurochem 104:777-789
9. Chen W, Rogatsky I, and Garabedian MJ (2006) MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor. Mol Endocrinol 20:560-572
10. Chivers JE, Gong W, King EM, Seybold J, Mak JC, Donnelly LE, Holden NS, and Newton R (2006) Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids. Mol Pharmacol 70:2084-2095
11. Chun JK, Seo DW, Ahn SH, Park JH, You JS, Lee CH, Lee JC, Kim YK, and Han JW (2007) Suppression of the NF-kappaB signalling pathway by ergolide, sesquiterpene lactone, in HeLa cells. J Pharm Pharmacol 59:561-566
12. De Bosscher K (2010) Selective glucocorticoid receptor modulators. J Steroid Biochem Mol Biol 120:96-104
13. De Bosscher K and Haegeman G (2009) Minireview: latest perspectives on antiinflammatory actions of glucocorticoids. Mol Endocrinol 23:281-291
14. De Bosscher K, Vanden Berghe W, and Haegeman G (2003) The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24:488-522
15. Eberhardt W, Kilz T, Akool S, Müller R, and Pfeilschifter J (2005) Dissociated glucocorticoids equipotently inhibit cytokine- and cAMP-induced matrix degrading proteases in rat mesangial cells. Biochem Pharmacol 70:433-445
16. Fagart J, Hillisch A, Huyet J, Bärfacker L, FayM, Pleiss U, Pook E, Schäfer S, Rafestin- Oblin ME, and Kolkhof P (2010) A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule. J Biol Chem 285:29932-29940
17. Flajollet S, Lefebvre B, Rachez C, and Lefebvre P (2006) Distinct roles of the steroid receptor coactivator 1 and of MED1 in retinoid-induced transcription and cellular differentiation. J Biol Chem 281:20338-20348
18. Gouilleux F, Sola B, Couette B, and Richard-Foy H (1991) Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter. Nucleic Acids Res 19:1563-1569
19. Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P, and Cato AC (1994) A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1 EMBO J 13:4087-4095
20. Hellal-Levy C, Couette B, Fagart J, Souque A, Gomez-Sanchez C, and Rafestin-Oblin M (1999) Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors. FEBS Lett 464:9-13
21. Humphrey EL, Williams JH, Davie MW, and Marshall MJ (2006) Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone 38:652-661
22. Kauppi B, Jakob C, Färnegardh M, Yang J, Ahola H, Alarcon M, Calles K, Engström O, Harlan J, and Muchmore S et al. (2003) The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem 278:22748-22754
23. Leo C and Chen JD (2000) The SRC family of nuclear receptor coactivators. Gene 245:1-11
24. Lind U, Greenidge P, Gillner M, Koehler KF, Wright A, and Carlstedt-Duke J (2000) Functional probing of the human glucocorticoid receptor steroid-interacting surface by site-directed mutagenesis. Gln-642 plays an important role in steroid recognition and binding. J Biol Chem 275:19041-19049
25. Nagy L and Schwabe JW (2004) Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci 29:317-324
26. Oakley RH and Cidlowski JA (2011) Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem 286:3177-3184
27. Pratt WB, Silverstein AM, and Galigniana MD (1999) A model for the cytoplasmic trafficking of signalling proteins involving the hsp90-binding immunophilins and p50cdc37 Cell Signal 11:839-851
28. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Näär AM, Erdjument- Bromage H, Tempst P, and Freedman LP (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398:824-828
29. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, and Angel P et al. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531-541
30. Reichardt HM, Tuckermann JP, Göttlicher M, Vujic M, Weih F, Angel P, Herrlich P, and Schütz G (2001) Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 20:7168-7173
31. Schäcke H, Döcke WD, and Asadullah K (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43
32. Schäcke H, Rehwinkel H, and Asadullah K (2005) Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index. Curr Opin Investig Drugs 6:503-507
33. Schmidt S, Rainer J, Ploner C, Presul E, Riml S, and Kofler R (2004) Glucocorticoidinduced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 11 (Suppl 1):S45-S55
34. Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, and Evans RM (1990) Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226
35. Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, Metzger D, Li M, and Chambon P (2011) Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145:224-241
36. Szapary D, Huang Y, and Simons SS, Jr (1999) Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol Endocrinol 13:2108-2121
37. Szapary D, Song LN, He Y, and Simons SS, Jr (2008) Differential modulation of glucocorticoid and progesterone receptor transactivation. Mol Cell Endocrinol 283:114-126
38. Szapary D, Xu M, and Simons SS, Jr (1996) Induction properties of a transiently transfected glucocorticoid-responsive gene vary with glucocorticoid receptor concentration. J Biol Chem 271:30576-30582
39. Tanigawa K, Tanaka K, Nagase H, Miyake H, Kiniwa M, and Ikizawa K (2002) Cell type-dependent divergence of transactivation by glucocorticoid receptor ligand. Biol Pharm Bull 25:1619-1622
40. Vayssière BM, Dupont S, Choquart A, Petit F, Garcia T, Marchandeau C, Gronemeyer H, and Resche-Rigon M (1997) Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol 11:1245-1255
41. Wang Q, Blackford JA, Jr, Song LN, Huang Y, Cho S, and Simons SS, Jr (2004) Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors. Mol Endocrinol 18:1376-1395
42. Yang-YenHF,Chambard JC, Sun YL, Smeal T, SchmidtTJ, Drouin J, andKarin M (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.